Published in Clin Endocrinol (Oxf) on July 03, 2007
Advances in biochemical screening for phaeochromocytoma using biogenic amines. Clin Biochem Rev (2009) 0.87
Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma. Case Rep Endocrinol (2011) 0.75
Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial. Gastroenterology (2007) 3.32
Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci (2010) 2.86
Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol (2006) 2.21
Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease - antibiotic use in the history does not play a significant role. Helicobacter (2004) 1.59
Budesonide 9 mg is at least as effective as mesalamine 4.5 g in patients with mildly to moderately active Crohn's disease. Gastroenterology (2010) 1.50
[Autoimmune pancreatitis]. Orv Hetil (2008) 1.43
Does dermatitis herpetiformis result in bone loss as coeliac disease does? A cross sectional study. Rev Esp Enferm Dig (2013) 1.40
[Appearing of bone marrow derived stem cells in healthy and regenerating colonic epithelium]. Orv Hetil (2009) 1.40
[Treatment prospects of lysosomal storage disorders]. Orv Hetil (2008) 1.40
Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers. PLoS One (2012) 1.35
Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients. Inflamm Bowel Dis (2009) 1.35
Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis. Endocr Relat Cancer (2009) 1.33
New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort. Am J Gastroenterol (2007) 1.27
Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature. Dis Markers (2008) 1.24
Crosstalk between TGF-β signaling and the microRNA machinery. Trends Pharmacol Sci (2012) 1.23
Changes of the cytokine profile in inflammatory bowel diseases. World J Gastroenterol (2012) 1.23
New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe. J Med Genet (2013) 1.22
Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors. J Bone Miner Res (2006) 1.20
Highly expressed genes are associated with inverse antisense transcription in mouse. J Genet (2007) 1.19
Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations. World J Gastroenterol (2005) 1.19
Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer. BMC Cancer (2008) 1.16
Diagnostic mRNA expression patterns of inflamed, benign, and malignant colorectal biopsy specimen and their correlation with peripheral blood results. Cancer Epidemiol Biomarkers Prev (2008) 1.15
Menin and its interacting proteins: elucidation of menin function. Trends Endocrinol Metab (2006) 1.15
Antioxidant measurements. Physiol Meas (2007) 1.14
Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: a novel liver disease biomarker. PLoS One (2010) 1.08
Three-dimensional virtual microscopy of colorectal biopsies. Arch Pathol Lab Med (2005) 1.06
Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients. Inflamm Bowel Dis (2007) 1.05
Herpes in STAT1 gain-of-function mutation [corrected]. Lancet (2012) 1.04
Wireless capsule endoscopy in the diagnosis of helminthiasis. Gastrointest Endosc (2007) 1.02
Dysplasia-carcinoma transition specific transcripts in colonic biopsy samples. PLoS One (2012) 1.01
Genetic screening methods for the detection of mutations responsible for multiple endocrine neoplasia type 1. Mol Genet Metab (2004) 1.01
Genetic polymorphisms of NOD1 and IL-8, but not polymorphisms of TLR4 genes, are associated with Helicobacter pylori-induced duodenal ulcer and gastritis. Helicobacter (2007) 1.01
Serrated pathway: alternative route to colorectal cancer. World J Gastroenterol (2013) 0.99
MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas. Mod Pathol (2010) 0.98
Update on the pharmacogenomics of proton pump inhibitors. Pharmacogenomics (2011) 0.98
MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas. Pituitary (2011) 0.97
[The problem of multiple testing and solutions for genome-wide studies]. Orv Hetil (2005) 0.97
Molecular detection of circulating cancer cells. Role in diagnosis, prognosis and follow-up of colon cancer patients. Dig Dis (2003) 0.97
Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island. BMC Cancer (2013) 0.97
Growth in epithelial cell proliferation and apoptosis correlates specifically to the inflammation activity of inflammatory bowel diseases: ulcerative colitis shows specific p53- and EGFR expression alterations. Dis Colon Rectum (2005) 0.97
The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer. Int J Mol Sci (2012) 0.96
Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis. World J Gastroenterol (2007) 0.96
Carcinogenesis in inflammatory bowel disease. Dig Dis (2007) 0.96
Potential biomarkers of colorectal adenoma-dysplasia-carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and 2 downregulated genes. Cell Oncol (2009) 0.96
Molecular pathogenesis of Helicobacter pylori infection: the role of bacterial virulence factors. Dig Dis (2010) 0.95
Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of disease. Mol Cancer Res (2007) 0.94
Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon. Pathol Oncol Res (2008) 0.94
Orolabial signs are important clues for diagnosis of the rare endocrine syndrome MEN 2B. Presentation of two unrelated cases. Eur J Pediatr (2007) 0.94
The role of the bone marrow derived mesenchymal stem cells in colonic epithelial regeneration. Pathol Oncol Res (2010) 0.93
Mutant p53 expression and apoptotic activity of Helicobacter pylori positive and negative gastritis in correlation with the presence of intestinal metaplasia. Eur J Gastroenterol Hepatol (2003) 0.93
MicroRNA-132 targets HB-EGF upon IgE-mediated activation in murine and human mast cells. Cell Mol Life Sci (2011) 0.93
Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy. Inflamm Bowel Dis (2007) 0.93
The behavior of matrix metalloproteinase-9 in lymphocytic colitis, collagenous colitis and ulcerative colitis. Pathol Oncol Res (2011) 0.93
Infliximab therapy improves the bone metabolism in fistulizing Crohn's disease. Dig Dis (2006) 0.93
Genome-wide screening of genes regulated by DNA methylation in colon cancer development. PLoS One (2012) 0.92
Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort. Inflamm Bowel Dis (2009) 0.92
The influence of methylated septin 9 gene on RNA and protein level in colorectal cancer. Pathol Oncol Res (2011) 0.92
The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases. Dig Dis (2012) 0.92
Effect of proton-pump inhibitor therapy on serum chromogranin a level. Digestion (2011) 0.91
Menin dynamics and functional insight: take your partners. Mol Cell Endocrinol (2010) 0.91
Elevated insulin-like growth factor 1 receptor, hepatocyte growth factor receptor and telomerase protein expression in mild ulcerative colitis. Scand J Gastroenterol (2008) 0.91
Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma. Endocr Pathol (2012) 0.91
Epithelial toll-like receptor 9 signaling in colorectal inflammation and cancer: clinico-pathogenic aspects. World J Gastroenterol (2013) 0.91
Difference of interleukin-23 receptor gene haplotype variants in ulcerative colitis compared to Crohn's disease and psoriasis. Inflamm Res (2012) 0.90
Clinical presentation of Crohn's disease. association between familial disease, smoking, disease phenotype, extraintestinal manifestations and need for surgery. Hepatogastroenterology (2005) 0.89
[Epidemiology, risk factors and molecular pathogenesis of primary liver cancer]. Orv Hetil (2008) 0.89
Role of DNA methylation in colorectal carcinogenesis. Dig Dis (2012) 0.89
Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program. Inflamm Bowel Dis (2015) 0.89
Automated classification of inflammation in colon histological sections based on digital microscopy and advanced image analysis. Cytometry A (2008) 0.88
Complete genes may pass from food to human blood. PLoS One (2013) 0.87
Have biologics changed the natural history of Crohn's disease? Dig Dis (2014) 0.87
Plasma carnitine ester profiles in Crohn's disease patients characterized for SLC22A4 C1672T and SLC22A5 G-207C genotypes. Br J Nutr (2007) 0.87
NKX2-3 and IRGM variants are associated with disease susceptibility to IBD in Eastern European patients. World J Gastroenterol (2010) 0.87
Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas. J Clin Endocrinol Metab (2010) 0.86
Significantly elevated Helicobacter pylori density and different genotype distribution in erosions as compared with normal gastric biopsy specimen detected by quantitative real-time PCR. Eur J Gastroenterol Hepatol (2008) 0.86
Cushing's syndrome in a child with pancreatic acinar cell carcinoma. Endocr Pathol (2007) 0.86
3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: a double-blind, double-dummy, randomised trial. J Crohns Colitis (2010) 0.85
Polymorphisms of the ApoE, HSD3B1, IL-1beta and p53 genes are associated with the development of early uremic complications in diabetic patients: results of a DNA resequencing array study. Int J Mol Med (2009) 0.85
BclI polymorphism of the glucocorticoid receptor gene is associated with decreased bone mineral density in patients with endogenous hypercortisolism. Clin Endocrinol (Oxf) (2009) 0.85
Chemoprevention of colorectal cancer: feasibility in everyday practice? Eur J Cancer Prev (2008) 0.85
Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer. J Cancer Res Clin Oncol (2003) 0.85
Protein microchips in biomedicine and biomarker discovery. Electrophoresis (2007) 0.85
Gastrointestinal stromal tumor presenting as a hormonally inactive adrenal mass. Endocrine (2011) 0.85
Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk. Dig Dis (2014) 0.85
Bone mineral density and bone acquisition in children and young adults with cystic fibrosis: a follow-up study. J Pediatr Gastroenterol Nutr (2004) 0.84
Laser microdissection in translational and clinical research. Cytometry A (2006) 0.84
Peptic esophageal stricture: medical treatment. Dig Dis (2009) 0.84
Regeneration associated growth factor receptor and epithelial marker expression in lymphoid aggregates of ulcerative colitis. Scand J Gastroenterol (2010) 0.84
[Risk factors for esophageal cancer, and possible genetic background]. Orv Hetil (2009) 0.84
Germline VHL gene mutations in Hungarian families with von Hippel-Lindau disease and patients with apparently sporadic unilateral pheochromocytomas. Eur J Endocrinol (2009) 0.84
Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study. Eur J Endocrinol (2009) 0.84
ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases. Scand J Gastroenterol (2007) 0.83